SecBot SecBot
8-K ·Filed Mar 5, 2026

COO

COOPER COMPANIES, INC.
BULLISH
Impact 8/10
Horizonweeks Processed8mo ago SEC0001628280-26-015231
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The combination of strong organic growth, margin expansion, and raised guidance suggests improving fundamentals. Traders should monitor the sustainability of CooperVision's premium product momentum and the company's ability to deliver on its increased free cash flow targets, which could support further share repurchases.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$76.36
T+0 close · Mar 5, 2026 · via day close
Latest settled
−21.18%
T+60 · $60.19
Vs SPY
−33.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 6 $76.36entry
  2. T+1 · 8mo ago −1.05%α −1.89% · $75.56
  3. T+5 · 8mo ago −8.59%α −7.06% · $69.80
  4. T+20 · 8mo ago −8.13%α −6.09% · $70.15
  5. T+60 · 6mo ago −21.18%α −33.96% · $60.19
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CooperCompanies reported strong first quarter 2026 results with revenue of $1.024 billion (up 6% YoY) and GAAP EPS of $0.66 (up 27% YoY), driven by growth in its CooperVision and CooperSurgical segments. The company raised its full-year 2026 guidance for non-GAAP EPS and free cash flow, citing strong profitability and cash generation.

Key Financial Metrics

Revenue
$1.0B
+6.0% YoY
Adj. EPS
$1.10
GAAP: $0.66
Guidance
$4.306 - $4.346 billion
raised
Free Cash Flow
$158.7M
Gross Margin
68%

Key Facts

  • Q1 2026 revenue: $1.024 billion, up 6% YoY (3% organically)
  • GAAP EPS: $0.66, up 27% YoY; Non-GAAP EPS: $1.10, up 20% YoY
  • Raised full-year 2026 guidance: non-GAAP EPS of $4.58-$4.66 and free cash flow of $600-$625 million
  • CooperVision revenue up 8% YoY; CooperSurgical revenue up 3% YoY
  • Repurchased $92.5 million of stock in the quarter

Financial Impact

Revenue increased by $59.4 million and GAAP EPS increased by $0.14 per share compared to the prior year quarter

revenueepsfreeCashFlowguidance

Segment Breakdown

SegmentRevenueGrowth
CooperVision$695.1M+8.0%
CooperSurgical$329.0M+3.0%

Risk Factors

  • Potential impact of tariffs on gross margin
  • Integration and execution risks related to reorganization initiatives
  • Foreign exchange rate fluctuations

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-015231
Document: coo-20260305.htm0001628280-26-015231
Document: 0001628280-26-015231-index-headers.html0001628280-26-015231
Document: 0001628280-26-015231-index.html0001628280-26-015231
Document: 0001628280-26-015231.txt0001628280-26-015231

Track record

10 reports on COO

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +7.83% at T+20 after the Jun 4, 2026 report. 2 of 5 went positive at some point.

Filters
  1. Oct 27, 202620d ago 8-K Bearish 6/10 Entry $59.41 Now $61.88 −4.16% settles Nov 25
  2. Oct 15, 20264w ago Institutional Cluster Bearish 4/10 Entry $57.40 to $62.93 Now $61.88 −7.80% ▼ −9.63% −11.05% vs SPY
  3. Sep 17, 20268w ago Insider Cluster Bullish 4/10 Entry $55.29 to $57.94 Now $61.88 +11.92% ▲ +4.79% +4.59% vs SPY
  4. Sep 15, 20268w ago Insider Cluster Neutral 2/10 Entry $54.61 to $54.88 Now $61.88 +13.31% ▲ +0.49% −1.57% vs SPY
  5. Sep 9, 20269w ago Press Release Mixed 6/10 Entry $54.17 to $54.30 Now $61.88 +14.23% ▲ +0.24% −1.88% vs SPY
  6. Jun 4, 202623w ago 8-K Mixed 6/10 No price data
  7. Jun 4, 202623w ago Press Release Bullish 6/10 Entry $67.34 to $72.61 Now $61.88 −8.11% ▲ +7.83% +5.96% vs SPY
  8. Mar 5, 202636w ago 8-K Bullish 8/10 Viewing Entry $76.36 to $70.15 Now $61.88 −18.97% ▼ −8.13% −6.09% vs SPY
  9. Mar 5, 202636w ago Press Release Bullish 8/10 Entry $76.36 to $70.15 Now $61.88 −18.97% ▼ −8.13% −6.09% vs SPY
  10. Feb 24, 202637w ago DEFA14A Neutral 2/10 Entry $83.38 to $71.35 Now $61.88 −25.79% ▼ −14.43% −9.19% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 9h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026